Most bought biotechnology stocks in Q1 2024
See which Biotechnology stocks institutional investors increased the most in Q1 2024, measured as net growth in reported share positions from Q4 2023 into Q1 2024. These rankings aggregate SEC 13F filings from all institutional investors in our database.
No data available.
No chart data.
Frequently asked questions about Most bought biotechnology stocks in Q1 2024
What are the most bought Biotechnology stocks in Q1 2024?
The most bought biotechnology stocks in Q1 2024 are those with the largest increase in reported share counts across institutional investors compared to Q4 2023, based on SEC 13F filings.
Which biotechnology stocks did institutional investors added to the most in Q1 2024?
The table above ranks tickers by net change in reported shares; when data is available, the largest increases appear at the top.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q4 2023).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.